Načítá se...
Five-year safety and performance results from the Argus II Retinal Prosthesis System clinical trial
PURPOSE: The Argus(®) II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA) was developed to restore some vision to patients blind from retinitis pigmentosa (RP) or outer retinal degeneration. A clinical trial was initiated in 2006 to study the long-term safety and efficacy...
Uloženo v:
| Vydáno v: | Ophthalmology |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5035591/ https://ncbi.nlm.nih.gov/pubmed/27453256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2016.06.049 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|